C-Reactive Protein and Gestational Diabetes: The Central Role of Maternal Obesity
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Acute-phase biomarkers such as C-reactive protein (CRP) and IL-6 have emerged as predictors of incident type 2 diabetes mellitus, implicating chronic subclinical inflammation as a factor in the pathophysiology of diabetes. Gestational diabetes (GDM) identifies a population of women at high risk of subsequent type 2 diabetes mellitus, representing an early stage in the natural history of the disease. In this context, we performed a cross-sectional study to determine whether markers of subclinical inflammation are elevated in patients with GDM. We studied 180 healthy pregnant women undergoing oral glucose tolerance testing in the late second or early third trimester. Based on oral glucose tolerance testing and prepregnancy body mass index (BMI), participants were stratified into four groups: 1) normal glucose tolerance (NGT) lean (BMI, <25 kg/m(2)) (n = 65); 2) NGT overweight (n = 28); 3) impaired glucose tolerance (n = 39); and 4) GDM (n = 48). Median CRP level was highest in overweight NGT subjects (8.8 mg/liter), followed by GDM (5.5 mg/liter), impaired glucose tolerance (4.4 mg/liter), and lean NGT (4.4 mg/liter) (overall P = 0.0297). CRP was significantly correlated with prepregnancy BMI (r = 0.38, P < 0.0001), followed by fasting insulin (r = 0.27, P = 0.0002) and fasting blood glucose (r = 0.18, P = 0.016). In multivariate linear regression analysis, prepregnancy BMI emerged as the most important determinant of CRP concentration, whereas glycemic tolerance status was not a significant factor. Furthermore, the observed stepwise increase in CRP per tertile of prepregnancy BMI was not significantly attenuated by glycemic tolerance status or factors known to be associated with GDM. In summary, we demonstrate that maternal serum levels of CRP are not related to GDM but rather correlate significantly with prepregnancy obesity. An independent contribution of CRP to risk of GDM could not be confirmed. These data suggest a model in which obesity mediates a systemic inflammatory response, with possible downstream metabolic sequelae, including insulin resistance and glucose dysregulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518 · cited 1×
“Previously implicated as a factor in obesity-related insulin resistance (29), TNF induces expression of IL-6, the principal determinant of hepatic CRP expression (30).”
BackgroundRidker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494 · cited 1×
“Several studies have firmly established the strong association between obesity and elevated inflammatory markers, leading to the recognition of obesity as a state of chronic low-grade inflammation (4, 23, 24).”
BackgroundYudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
Cited by
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
“of leptin (41) and the inflammatory markers TNF-α (42) and C-reactive protein (43) and decreased levels of adiponectin (44, 45) in women with GDM.”
BackgroundFain, J. N., Madan, A. K., Hiler, M. L., Cheema, P., & Bahouth, S. W. (2004) · Endocrinology · doi:10.1210/en.2003-1336 · Cited by 1,572
Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study
Villamor, E., & Cnattingius, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69473-7 · Cited by 756
Gestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677
Inflammation in maternal obesity and gestational diabetes mellitus
Pantham, P., Aye, I. L. M. H., & Powell, T. L. (2015) · Placenta · doi:10.1016/j.placenta.2015.04.006 · Cited by 582
Buchanan, T. A., Xiang, A., Kjos, S. L., & Watanabe, R. (2007) · Diabetes Care · doi:10.2337/dc07-s201 · Cited by 417
The Human Placenta in Gestational Diabetes Mellitus
Desoye, G., & Hauguel-de Mouzon, S. (2007) · Diabetes Care · doi:10.2337/dc07-s203 · Cited by 355
Prepregnancy Obesity and Fetal Death: A Study Within the Danish National Birth Cohort
Nohr, E. A., Bech, B. H., Davies, M. J., Frydenberg, M., Henriksen, T. B., & Olsen, J. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000172422.81496.57 · Cited by 351
Obesity and Pregnancy—The Propagation of a Viscous Cycle?
Catalano, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031046 · Cited by 325
The Placenta Cytokine Network and Inflammatory Signals
Hauguel-de Mouzon, S., & Guerre-Millo, M. (2006) · Placenta · doi:10.1016/j.placenta.2005.08.009 · Cited by 294
Gestational Diabetes, Pregnancy Hypertension, and Late Vascular Disease
Carpenter, M. W. (2007) · Diabetes Care · doi:10.2337/dc07-s224 · Cited by 282
Peroxynitrite and Vascular Endothelial Dysfunction in Diabetes Mellitus
Zou, M.-H., Cohen, R. A., & Ullrich, V. (2004) · Endothelium · doi:10.1080/10623320490482619 · Cited by 270
Christian, L. M., & Porter, K. (2014) · Cytokine · doi:10.1016/j.cyto.2014.06.018 · Cited by 268
Inequalities in perinatal and maternal health
de Graaf, J. P., Steegers, E. A. P., & Bonsel, G. J. (2013) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32835ec9b0 · Cited by 190
Reduced Adiponectin Concentration in Women With Gestational Diabetes
Retnakaran, R., Hanley, A. J. G., Raif, N., Connelly, P. W., Sermer, M., & Zinman, B. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.799 · Cited by 160
Self-citationGestational Diabetes: Implications for Cardiovascular Health
Sullivan, S. D., Umans, J. G., & Ratner, R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-011-0238-3 · Cited by 143
Dietary Patterns during Pregnancy Are Associated with Risk of Gestational Diabetes Mellitus
Shin, D., Lee, K., & Song, W. (2015) · Nutrients · doi:10.3390/nu7115472 · Cited by 133
“In contrast, maternal serum levels of CRP were not associated with the risk for GDM but significantly correlated with prepregnancy obesity in a cross-sectional study [48].”
BackgroundChen, X., Scholl, T. O., & Stein, T. P. (2006) · Diabetes Care · doi:10.2337/dc06-0164 · Cited by 122
Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome
Bo, S., Monge, L., Macchetta, C., Menato, G., Pinach, S., Uberti, B., & Pagano, G. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347494 · Cited by 63
Obesity and Pregnancy, the Perfect Metabolic Storm
Corrales, P., Vidal-Puig, A., & Medina-Gómez, G. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00914-5 · Cited by 51
Tranidou, A., Dagklis, T., Tsakiridis, I., Siargkas, A., Apostolopoulou, A., Mamopoulos, A., Goulis, D. G., & Chourdakis, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01464-6 · Cited by 43
Clapperton, M., Jarvis, J., & Mungrue, K. (2009) · Obstetrics and Gynecology International · doi:10.1155/2009/289329 · Cited by 9
Metadata
- Authors
- Retnakaran, R., Hanley, A. J. G., Raif, N., Connelly, P. W., Sermer, M., & Zinman, B.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-08
- Volume
- 88
- Issue
- 8
- Pages
- 3507-3512
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2015970974
- Cited by
- 243
- References
- 32
- FWCI
- 14.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.